title: Enterovirus infection of neuronal cells post-Rituximab.
authors.forename: Sorena
authors.initials: S
authors.lastname: Kiani-Alikhan
authors.forename: Ferdinandos
authors.initials: F
authors.lastname: Skoulidis
authors.forename: Ana
authors.initials: A
authors.lastname: Barroso
authors.forename: Gerard
authors.initials: G
authors.lastname: Nuovo
authors.forename: Ines
authors.initials: I
authors.lastname: Ushiro-Lumb
authors.forename: Judith
authors.initials: J
authors.lastname: Breuer
authors.forename: Andrew
authors.initials: A
authors.lastname: Lister
authors.forename: Frank
authors.initials: F
authors.lastname: Mattes
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002524:Cerebellar Ataxia / Q000139:chemically induced / Q000821:virology; D004769:Enterovirus Infections / Q000139:chemically induced*; D017809:Fatal Outcome; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008590:Meningoencephalitis / Q000139:chemically induced* / Q000821:virology; D008875:Middle Aged; D009474:Neurons / Q000821:virology*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab